Epidemiology and management of hypertension in the Hispanic population: a review of the available literature.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Nicolas J Guzman

Abstract

Hispanics are the fastest growing ethnic minority in the USA. Among Hispanics, lack of hypertension awareness and lack of effective blood pressure (BP) control are problematic, as are higher incidence rates of hypertension-related co-morbidities compared with non-Hispanic populations. Moreover, there are currently no hypertension treatment guidelines that address the unique characteristics of this ethnic group. This article discusses ethnic differences in hypertension and cardiovascular risk factors and reviews the literature on the efficacy of antihypertensive agents in Hispanic patients, with a focus on the role of renin-angiotensin-aldosterone system (RAAS) inhibition in the management of hypertension in these patients. Hypertension in Hispanic patients can be challenging to manage, in part because this population has a higher prevalence of obesity, diabetes, and metabolic syndrome compared with non-Hispanic whites. The presence of these co-morbidities suggests that RAAS-inhibitor-based therapies may be particularly beneficial in this population. However, few studies have evaluated the efficacy of antihypertensive treatments in Hispanic patients. Two outcomes studies in hypertensive patients have shown the benefits of treati...Continue Reading

References

Nov 24, 1993·JAMA : the Journal of the American Medical Association·P D SorlieE Rogot
Jan 21, 2000·Preventive Medicine·M P Stern, M Wei
Jul 23, 2002·Journal of General Internal Medicine·Scott H Stewart, Marc D Silverstein
Jan 31, 2003·The Journal of Clinical Hypertension·Robert A PhillipsMyron Weinberger
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 23, 2004·American Journal of Epidemiology·Kushang V PatelKyriakos S Markides
Jul 21, 2004·Journal of the American College of Cardiology·Charles K FrancisRichard C Wong
Jun 23, 2005·Social Science & Medicine·Ana F Abraído-LanzaKaren R Flórez
Dec 29, 2005·American Journal of Public Health·David P Smith, Benjamin S Bradshaw
Jun 15, 2007·European Heart Journal·Giuseppe Mancia The task force for the management of arterial hypertension of the European Society of Cardiology
Sep 12, 2007·Hypertension·Karen L MargolisUNKNOWN Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Jan 22, 2008·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Yagiz UresinAndrew Satlin
Apr 4, 2009·Journal of the American College of Cardiology·Rey P VivoRonald M Witteles
Oct 27, 2009·Journal of General Internal Medicine·Andrea BersaminMarilyn A Winkleby
Nov 10, 2009·Public Health Reports·Pracha P EamranondSuzanne G Leveille
Nov 26, 2009·Patient Preference and Adherence·Luis O RustveldRobert J Volk
Jan 6, 2010·The Journal of Clinical Hypertension·Adam Whaley-ConnellUNKNOWN KEEP Investigators
Jun 24, 2010·Journal of General Internal Medicine·Ana H TraylorUsha Subramanian
Oct 6, 2010·Hypertension·John M FlackUNKNOWN International Society on Hypertension in Blacks
Nov 23, 2010·Therapeutic Advances in Cardiovascular Disease·Henry Punzi Wei Chen
Mar 19, 2011·Journal of the American Society of Hypertension : JASH·Keith C FerdinandEdgar A Jaimes
Apr 2, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kenneth S Hershon
Apr 7, 2011·The Journal of Clinical Hypertension·Willa A Hsueh, Kathleen Wyne

❮ Previous
Next ❯

Citations

Dec 26, 2015·International Journal of Environmental Research and Public Health·Marina MartinezChelsea Kidwell
May 2, 2014·Pharmacology & Therapeutics·Nina SchlueterAndreas L Birkenfeld
Feb 24, 2015·Advances in Chronic Kidney Disease·Fátima Rodriguez, Keith C Ferdinand
Sep 10, 2013·Journal of Immigrant and Minority Health·Irma N RamosKenneth S Ramos
Nov 4, 2016·The Korean Journal of Internal Medicine·Nonanzit Pérez-HernándezRuben Blachman-Braun
May 24, 2014·Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society·Eleanor HallJulia Perilla
Oct 7, 2017·American Journal of Hypertension·Carolyn H StillUNKNOWN SPRINT Writing Group
Apr 27, 2018·PLoS Computational Biology·Ji-Sung KimAndrey Rzhetsky
Sep 12, 2019·Hispanic Health Care International : the Official Journal of the National Association of Hispanic Nurses·Wen-Wen LiYoshimi Fukuoka
Oct 19, 2019·Journal of General Internal Medicine·Antoinette SchoenthalerMilagros C Rosal
May 3, 2019·Current Opinion in Cardiology·Claudia L Campos, Carlos J Rodriguez
Feb 24, 2020·Health and Quality of Life Outcomes·Vered Kaufman-ShriquiUNKNOWN Community Child Health Network (CCHN) of Eunice Kennedy Shriver National Institute of Child Health and Human Development
Feb 9, 2021·World Journal of Surgery·Gustavo Romero-VelezJohn C McAuliffe

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00654745
NCT00705575
NCT00772577
NCT00942994

Software Mentioned

EVALUATE
ALLHAT
INVEST
INVE

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.